290 related articles for article (PubMed ID: 30860438)
1. Recent clinical trials of immunotherapy in non-small-cell lung cancer.
Gkolfinopoulos S; Mountzios G
Immunotherapy; 2019 Apr; 11(6):461-466. PubMed ID: 30860438
[No Abstract] [Full Text] [Related]
2. Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer.
Cooper MR; Alrajhi AM; Durand CR
Am J Ther; 2018; 25(3):e349-e356. PubMed ID: 29722737
[TBL] [Abstract][Full Text] [Related]
3. Current uses of check inhibitors in the fight against advanced and/or metastatic lung cancer: will immunotherapy overcome chemotherapy?
Cetin B; Bilgetekin İ; Ozet A
Curr Probl Cancer; 2019 Feb; 43(1):43-53. PubMed ID: 30104030
[TBL] [Abstract][Full Text] [Related]
4. [The role of immune checkpoint inhibitors in lung cancer: from clinical trials to clinical practice].
Wang ZM; Song Y
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):95-99. PubMed ID: 32062879
[TBL] [Abstract][Full Text] [Related]
5. Non-small-cell lung cancer: what are the benefits and challenges of treating it with immune checkpoint inhibitors?
Rassy E; Mezquita L; Remon J; Besse B
Immunotherapy; 2019 Sep; 11(13):1149-1160. PubMed ID: 31361172
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitors in Lung Cancer and Melanoma.
Madden K; Kasler MK
Semin Oncol Nurs; 2019 Oct; 35(5):150932. PubMed ID: 31561846
[TBL] [Abstract][Full Text] [Related]
7. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
Santana-Davila R; Chow LQ
Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
[No Abstract] [Full Text] [Related]
8. Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.
Garon EB
Semin Oncol; 2015 Oct; 42 Suppl 2():S11-8. PubMed ID: 26477470
[TBL] [Abstract][Full Text] [Related]
9. Supportive care in the era of immunotherapies for advanced non-small-cell lung cancer.
Awada G; Klastersky J
Curr Opin Oncol; 2018 Mar; 30(2):98-104. PubMed ID: 29303787
[TBL] [Abstract][Full Text] [Related]
10. [Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer].
Fu MJ; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):87-91. PubMed ID: 32062877
[TBL] [Abstract][Full Text] [Related]
11. The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers.
Gelsomino F; Lamberti G; Parisi C; Casolari L; Melotti B; Sperandi F; Ardizzoni A
Cancer Treat Rev; 2019 Sep; 79():101887. PubMed ID: 31491661
[TBL] [Abstract][Full Text] [Related]
12. The Changing Treatment Landscape for Metastatic Urothelial Carcinoma.
Flaig TW
J Natl Compr Canc Netw; 2018 May; 16(5S):636-638. PubMed ID: 29784744
[TBL] [Abstract][Full Text] [Related]
13. Principles of Immunotherapy in Non-Small Cell Lung Cancer.
Hsu ML; Naidoo J
Thorac Surg Clin; 2020 May; 30(2):187-198. PubMed ID: 32327177
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Advanced Non-Small Cell Lung Cancer in 2018.
Doroshow DB; Herbst RS
JAMA Oncol; 2018 Apr; 4(4):569-570. PubMed ID: 29494728
[No Abstract] [Full Text] [Related]
15. Immunotherapy combinations emerging in non-small-cell lung cancer.
Chao YL; Pecot CV
Immunotherapy; 2018 Jun; 10(8):627-629. PubMed ID: 29882690
[No Abstract] [Full Text] [Related]
16. Combining immunotherapies to treat non-small cell lung cancer.
Spagnuolo A; Gridelli C
Expert Rev Respir Med; 2019 Jul; 13(7):621-634. PubMed ID: 31116072
[No Abstract] [Full Text] [Related]
17. Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab.
Passiglia F; Galvano A; Rizzo S; Incorvaia L; Listì A; Bazan V; Russo A
Int J Cancer; 2018 Mar; 142(6):1277-1284. PubMed ID: 29080213
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in the treatment of non-small cell lung cancer.
Sundar R; Soong R; Cho BC; Brahmer JR; Soo RA
Lung Cancer; 2014 Aug; 85(2):101-9. PubMed ID: 24880938
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions.
Yan YF; Zheng YF; Ming PP; Deng XX; Ge W; Wu YG
Brief Funct Genomics; 2019 Mar; 18(2):147-156. PubMed ID: 30247518
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for small-cell lung cancer: emerging evidence.
Reck M; Heigener D; Reinmuth N
Future Oncol; 2016 Apr; 12(7):931-43. PubMed ID: 26882955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
